Riskpilot← Back to searchSign inGet full accessRobbo Medical AB
ABActiveOrg 5591611180Askims Domarringsväg 147General medical practice activities · NACE 8621Est. 20180 employees
Revenue 2024
SEK 112K
-16% vs 2023
EBITDA margin
52.7%
-9% vs 2023
Equity ratio
86.4%
Financial strength
Net profit 2024
SEK -116K
-327% vs 2023
| Revenue | SEK 112K | -16% |
| EBITDA | SEK 59K | -9% |
| Net profit | SEK -116K | -327% |
| Total assets | SEK 295K | -25% |
| Equity | SEK 255K | -31% |
| Employees | 0 | — |
Legal name
Robbo Medical AB
Org number
5591611180
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
1 juni 2018
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-11-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Konsultverksamhet för läkare, uthyrning av sjukvårdspersonal, äga och förvalta aktier och andelar i andra bolag och därmed förenlig verksamhet.
Address
Askims Domarringsväg 147
Email
robin.bogdanffy@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 86 | 240 | 99 | 133 | 112 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 25 | 190 | 52 | 65 | 59 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 25 | 190 | 52 | 65 | 59 |
| Net financials | — | −1 | — | — | −326 |
| Profit before tax | 24 | 189 | 53 | 66 | −104 |
| Tax | −5 | −39 | −11 | −15 | −12 |
| Net profit | 19 | 150 | 42 | 51 | −116 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 356 | 485 | 403 | 391 | 295 |
| Equity | 229 | 379 | 320 | 371 | 255 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 127 | 106 | 82 | 20 | 40 |
| Total debt | 127 | 106 | 82 | 20 | 40 |
EBITDA margin
52.7%
This company
15.8%
Market median
+234% vs market
20202024
Equity ratio
86.4%
This company
38.2%
Market median
+126% vs market
20202024
Return on equity
-45.5%
This company
18.4%
Market median
-347% vs market
20202024
Net profit margin
-103.6%
This company
8.1%
Market median
-1379% vs market
20202024
Asset turnover
0.38×
This company
1.12×
Market median
-66% vs market
20202024
Debt / equity
0.16×
This company
0.62×
Market median
+74% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-12-01 – 2024-11-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-12-01 – 2023-11-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-12-01 – 2022-11-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-12-01 – 2021-11-30
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-12-01 – 2020-11-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
RA Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Robbo Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Robin Alex Bogdanffy | Chief Executive Officer | 0 companies |
| Ioana Morar Bogdanffy | Deputy Board Member | 0 companies |
| Constantin Bogdanffy | Deputy Board Member | 0 companies |